| mRNA |
SGX-523 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
9e-12 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
5e-09 |
| mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-06 |
| mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-06 |
| mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
| mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |
| mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
| mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
| mRNA |
RO-3306 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.15 |
0.002 |